Reuters logo
BRIEF-Hikma launches serious infections treatment in the United States
November 3, 2017 / 9:04 AM / 19 days ago

BRIEF-Hikma launches serious infections treatment in the United States

Nov 3 (Reuters) - HIKMA PHARMACEUTICALS PLC:

* HIKMA LAUNCHES FLUCYTOSINE CAPSULES USP IN US

* ‍CAPSULES ARE INDICATED FOR TREATMENT OF SERIOUS INFECTIONS CAUSED BY SUSCEPTIBLE STRAINS OF CANDIDA AND/OR CRYPTOCOCCUS​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below